our mission: to be the world’s leader in imaging components through the delivery of high-quality products that enables our customers’ success. our vision: to create the most innovative and cost-effective x-ray imaging solutions for equipment manufacturers. varex imaging corporation is the world’s largest independent supplier of medical x-ray tubes and image processing solutions. from medical imaging to cargo screening and border security, our components are used by x-ray imaging system manufacturers everywhere to detect, diagnose, and protect. our products are designed to harness the power of x-ray energy to pioneer advances in any application. this requires us to maintain an extensive catalog, and we are a leading supplier of high-voltage connectors, x-ray collimators, ionization chambers, mammography paddles, solid state automatic exposure control systems and buckies for digital imaging. as a leader in imaging components, our goal is to help our customers become world-class system su
Company profile
Ticker
VREX
Exchange
Website
CEO
Sunny Sanyal
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
3901 Carnation Street, LLC • Direct Conversion Ltd • Irradiation Systems, LLC • MeVis Medical Solutions AG • Oy Varex Imaging Finland Ltd. • Varex Imaging Americas Corporation • Varex Imaging Arabia, LLC • Varex Imagens Brasil, Ltda. • Varex Imaging Deutschland AG • Varex Imaging Deutschland Innovation I GMBH ...
VREX stock data
Latest filings (excl ownership)
8-K
Varex Announces Closing of Revolving
27 Mar 24
S-8
Registration of securities for employees
16 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
9 Feb 24
10-Q
2024 Q1
Quarterly report
6 Feb 24
8-K
Varex Announces Financial Results for First Quarter Fiscal Year 2024
6 Feb 24
DEFA14A
Additional proxy soliciting materials
27 Dec 23
DEF 14A
Definitive proxy
27 Dec 23
8-K
Other Events
17 Nov 23
10-K
2023 FY
Annual report
16 Nov 23
8-K
Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2023
14 Nov 23
Transcripts
VREX
Earnings call transcript
2024 Q1
6 Feb 24
VREX
Earnings call transcript
2023 Q4
14 Nov 23
VREX
Earnings call transcript
2023 Q3
1 Aug 23
VREX
Earnings call transcript
2023 Q2
2 May 23
VREX
Earnings call transcript
2023 Q1
31 Jan 23
VREX
Earnings call transcript
2022 Q4
16 Nov 22
VREX
Earnings call transcript
2022 Q3
3 Aug 22
VREX
Earnings call transcript
2022 Q2
9 May 22
VREX
Earnings call transcript
2022 Q1
9 Feb 22
VREX
Earnings call transcript
2021 Q4
17 Nov 21
Latest ownership filings
4
Kimberley E. Honeysett
19 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
4
SUNNY SANYAL
20 Feb 24
4
Mark S. Jonaitis
20 Feb 24
4
Andrew Hartmann
20 Feb 24
4
Kimberley E. Honeysett
20 Feb 24
SC 13G
SHAPIRO CAPITAL MANAGEMENT LLC
14 Feb 24
SC 13G
COOKE & BIELER LP
13 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
3
Karen L Aranki
13 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 23 | Sep 22 | Oct 21 | Oct 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 185 |
Opened positions | 26 |
Closed positions | 22 |
Increased positions | 66 |
Reduced positions | 48 |
13F shares | Current |
---|---|
Total value | 813.20 bn |
Total shares | 43.61 mm |
Total puts | 112.60 k |
Total calls | 28.20 k |
Total put/call ratio | 4.0 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 7.51 mm | $141.09 bn |
Vanguard | 4.58 mm | $86.01 bn |
Allspring Global Investments | 3.02 mm | $56.71 bn |
Shapiro Capital Management | 2.57 mm | $48.35 bn |
Cooke & Bieler | 2.46 mm | $46.16 bn |
Dimensional Fund Advisors | 2.37 mm | $44.60 bn |
STT State Street | 1.95 mm | $36.65 bn |
Frontier Capital Management | 1.83 mm | $34.37 bn |
Pzena Investment Management | 1.11 mm | $20.93 bn |
Millennium Management | 1.08 mm | $20.37 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Mar 24 | Kimberley E. Honeysett | Common Stock | Sell | Dispose S | No | Yes | 17.37 | 2,860 | 49.68 k | 2,853 |
11 Feb 24 | Jocelyn D Chertoff | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,881 | 0.00 | 27,138 |
11 Feb 24 | Jocelyn D Chertoff | Deferred Stock Units Common Stock | Option exercise | Dispose M | No | No | 0 | 6,881 | 0.00 | 0 |
11 Feb 24 | Tsingos Christine A | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,881 | 0.00 | 27,599 |
11 Feb 24 | Tsingos Christine A | Deferred Stock Units Common Stock | Option exercise | Dispose M | No | No | 0 | 6,881 | 0.00 | 0 |
11 Feb 24 | Jay K. Kunkel | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,881 | 0.00 | 18,479 |
11 Feb 24 | Jay K. Kunkel | Deferred Stock Units Common Stock | Option exercise | Dispose M | No | No | 0 | 6,881 | 0.00 | 0 |
8 Feb 24 | Jocelyn D Chertoff | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 9,643 | 0.00 | 9,643 |
8 Feb 24 | Bardwell Kathleen | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 9,643 | 0.00 | 9,643 |
8 Feb 24 | Tsingos Christine A | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 9,643 | 0.00 | 9,643 |
News
Varex Imaging Sees Q2 EPS $0.10-$0.30 Vs $0.21 Est.; Revenue $195M-$215M Vs $206.87M Est.
6 Feb 24
12 Health Care Stocks Moving In Tuesday's After-Market Session
6 Feb 24
Recap: Varex Imaging Q1 Earnings
6 Feb 24
Varex Imaging Q1 Adj $0.06 Misses $0.11 Estimate, Sales $190.00M Beat $187.97M Estimate
6 Feb 24
Earnings Scheduled For February 6, 2024
6 Feb 24